logo

For the Inventor, By the Inventor

Brooklyn Park, MN, United States of America

Cima Labs Inc.


USPTO Granted Patents = 41

% Expired Patents = 19.5



Trademarks = 5

Forward Citations = 2,431

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Rajendra K Khankari (15 out of 19 patents)

silverMedal John Hontz (15 out of 19 patents)

bronzeMedal S Indiran Pather (10 out of 11 patents)

4.  Joseph R Robinson (9 out of 28 patents)

5.  Jonathan D Eichman (9 out of 14 patents)

6.  Manuel A Vega Zepeda (8 out of 14 patents)

7.  Derek V Moe (8 out of 20 patents)

8.  Walid A Habib (7 out of 7 patents)

9.  Sangeeta V Gupte (7 out of 7 patents)

10.  Ehab Hamed (6 out of 6 patents)

11.  Fred Wehling (5 out of 15 patents)

12.  Steve Schuehle (5 out of 5 patents)

13.  Dinesh K Haswani (4 out of 10 patents)

14.  Victoria Ann O'Neill (4 out of 19 patents)

15.  Navayanarao Madamala (4 out of 4 patents)


Core Competencies:
Abuse-Resistant Drug Formulation
Effervescent Dosage Form
Child Resistant Package
Sublingual Buccal Effervescent
Taste Masking
Rapidly Dissolving Dosage Form
Granulated Dosage Forms
Sequential Drug Delivery Systems
Pharmaceutical Compositions
Microemulsions
Tablet Packaging
Organoleptically Pleasant

41 patents:

1. 10201505 - Immediate release abuse-deterrent granulated dosage forms (2019-02-12),
2. 9974751 - Abuse resistant drug formulation (2018-05-22),
3. 9827204 - Immediate release abuse-deterrent granulated dosage forms (2017-11-28),
4. 9757371 - Immediate release abuse-deterrent granulated dosage forms (2017-09-12),
5. 9707224 - Immediate release abuse-deterrent granulated dosage forms (2017-07-18),
6. 9572803 - Abuse resistant drug formulation (2017-02-21),
7. 9474721 - Abuse-resistant formulations (2016-10-25),
8. 9216176 - Abuse resistant drug formulation (2015-12-22),
9. 8927025 - Alcohol-resistant metoprolol-containing extended-release oral dosage forms (2015-01-06),
10. 8637076 - Prednisolone salt formulations (2014-01-28),
11. 8445018 - Abuse resistant drug formulation (2013-05-21),
12. 8191711 - Bend and peel tablet package (2012-06-05),
13. 7862833 - Effervescent oral opiate dosage forms and methods of administering opiates (2011-01-04),
14. 7862832 - Generally linear effervescent oral fentanyl dosage form and methods of administering (2011-01-04),
15. 7858121 - Effervescent oral fentanyl dosage form and methods of administering fentanyl (2010-12-28),
Cima Labs Inc., based in Brooklyn Park, MN, specializes in the development and manufacturing of innovative drug delivery systems. The company focuses on creating abuse deterrent formulations and rapidly dissolving dosage forms, enhancing patient safety and medication adherence. Cima Labs is recognized for its expertise in effervescent drug delivery, sublingual buccal delivery, and child-resistant packaging, as well as taste masking systems and microemulsions, contributing to advancements in oral dosage forms.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

41 Patents

#3 in Brooklyn Park, MN

#245 in Minnesota

#8,427 in US

#16,669 in the World

Brooklyn Park, MN (US)
Brooklyn Park, MN, United States of America

Cima Labs Inc.

Forward Citations = 2,431

36 inventors:

goldMedal Rajendra K Khankari (15 out of 19 patents)

silverMedal John Hontz (15 out of 19 patents)

bronzeMedal S Indiran Pather (10 out of 11 patents)

4.  Joseph R Robinson (9 out of 28 patents)

5.  Jonathan D Eichman (9 out of 14 patents)

Please report any incorrect information to [email protected]
Loading…